Lab
Slocum Dickson Medical Group PLLC
Slocum Dickson Medical Group PLLC was paid $54.06M by Medicaid between Jan 2018 and Dec 2024, across 328 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoSLOCUM DICKSON MEDICAL GROUP PLLC
NEW HARTFORD, NY 13413
NEW HARTFORD, NY 13413
33aNPI1285625996assigned 11/02/2005
33bProvider typeClinical Medical Laboratory
28Total paid$54.06M
24GClaims1,398,165
24DCodes billed328
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in New York
Rank by total paid#9 of 116
Median peer was paid$618K
This provider vs. median87×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 143,118 | $5.00M | |
| 2019 | 158,033 | $5.67M | |
| 2020 | 183,094 | $6.50M | |
| 2021 | 235,217 | $9.91M | |
| 2022 | 262,983 | $10.57M | |
| 2023 | 240,136 | $10.00M | |
| 2024incomplete | 175,584 | $6.40M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 131,988 | 122,497 | $14.50M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 120,136 | 108,270 | $8.91M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.8% | 12,893 | 12,886 | $2.05M |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.5% | 9,710 | 9,469 | $1.34M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.0% | 10,733 | 10,729 | $1.09M |
| 17110 | 2.0% | 4,863 | 2,311 | $1.07M | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.6% | 17,851 | 8,338 | $889K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.6% | 8,326 | 8,324 | $846K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.5% | 8,636 | 8,496 | $812K |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | 1.5% | 458 | 439 | $806K |
| 20611 | 1.4% | 3,123 | 1,602 | $740K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.3% | 23,157 | 23,070 | $697K |
316 more codes
| 80053 | Comprehensive metabolic panel | 1.2% | 62,310 | $649K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.2% | 8,640 | $635K |
| 99203 | Doctor's office visit, new patient (routine) | 1.2% | 6,043 | $631K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.1% | 5,241 | $603K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 33,065 | $538K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 4,406 | $531K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 4,718 | $525K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 63,062 | $483K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 27,659 | $482K |
| 80061 | Lipid panel | <1% | 35,312 | $475K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 3,819 | $438K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 7,052 | $424K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 3,283 | $399K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 9,160 | $358K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 9,157 | $358K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 581 | $351K |
| 80305 | <1% | 27,021 | $334K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,041 | $321K |
| 62323 | <1% | 905 | $299K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 8,239 | $298K |
| 82607 | <1% | 18,710 | $286K | |
| 87481 | <1% | 2,105 | $281K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,924 | $278K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 7,607 | $275K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 17,450 | $266K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,742 | $257K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 25,747 | $243K |
| 80050 | General health panel | <1% | 6,764 | $237K |
| 82728 | <1% | 17,661 | $235K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,257 | $234K |
| 76536 | <1% | 2,104 | $222K | |
| 58558 | <1% | 247 | $222K | |
| 87480 | <1% | 9,272 | $194K | |
| 84439 | <1% | 21,288 | $194K | |
| 20610 | <1% | 891 | $180K | |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 212 | $168K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 80 | $167K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,008 | $165K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 19,271 | $164K |
| 27096 | <1% | 510 | $147K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,612 | $146K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,544 | $137K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,085 | $136K |
| 99205 | Prolong outpt/office vis | <1% | 645 | $131K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,258 | $130K |
| 83550 | <1% | 14,394 | $122K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,067 | $114K |
| 73630 | <1% | 3,517 | $110K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,366 | $109K |
| 86780 | <1% | 7,406 | $107K | |
| 59025 | Fetal non-stress test | <1% | 2,400 | $106K |
| 97161 | <1% | 1,247 | $103K | |
| 86003 | <1% | 1,043 | $102K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 4,716 | $98K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,314 | $97K |
| 99406 | <1% | 7,009 | $96K | |
| 84702 | <1% | 5,845 | $96K | |
| 83540 | <1% | 15,173 | $96K | |
| 87660 | <1% | 3,927 | $91K | |
| 87510 | <1% | 3,853 | $90K | |
| 87081 | <1% | 11,882 | $87K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,070 | $87K |
| 83516 | <1% | 1,807 | $85K | |
| 81001 | <1% | 25,842 | $85K | |
| 94729 | <1% | 1,630 | $85K | |
| 82746 | <1% | 5,635 | $82K | |
| 94726 | <1% | 1,603 | $80K | |
| 86235 | <1% | 1,985 | $79K | |
| 84403 | <1% | 2,628 | $74K | |
| 72110 | <1% | 1,601 | $74K | |
| 95024 | <1% | 461 | $70K | |
| 76642 | <1% | 619 | $68K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 825 | $67K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,497 | $67K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 494 | $67K |
| 76830 | Ultrasound, transvaginal | <1% | 655 | $66K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,414 | $66K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 481 | $65K |
| 94060 | <1% | 1,393 | $64K | |
| 73030 | <1% | 2,054 | $62K | |
| 73564 | <1% | 1,420 | $61K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 609 | $60K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 7,724 | $60K |
| 90686 | <1% | 9,178 | $59K | |
| 83735 | <1% | 8,717 | $57K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 347 | $52K |
| 90682 | <1% | 790 | $49K | |
| 86140 | <1% | 9,856 | $49K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 294 | $47K |
| 95117 | <1% | 4,365 | $47K | |
| 73562 | <1% | 1,263 | $47K | |
| 86038 | <1% | 3,469 | $46K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 396 | $45K |
| 82043 | <1% | 7,966 | $45K | |
| 85027 | <1% | 6,629 | $45K | |
| 84146 | <1% | 2,187 | $45K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 531 | $45K |
| 82784 | <1% | 2,593 | $44K | |
| 84153 | <1% | 2,153 | $44K | |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 3,463 | $40K |
| 73610 | <1% | 1,190 | $40K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 968 | $40K |
| 84480 | <1% | 2,572 | $39K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,745 | $39K |
| 86225 | <1% | 2,590 | $39K | |
| 99385 | <1% | 296 | $38K | |
| 64615 | <1% | 208 | $38K | |
| 76801 | <1% | 322 | $37K | |
| J2315 | Injection, naltrexone, depot form, 1 mg | <1% | 29 | $37K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 963 | $36K |
| 77002 | <1% | 384 | $34K | |
| 87186 | <1% | 3,581 | $34K | |
| 84703 | <1% | 4,095 | $33K | |
| 86160 | <1% | 2,440 | $32K | |
| 80074 | <1% | 670 | $32K | |
| 82670 | <1% | 1,041 | $31K | |
| 83001 | <1% | 1,581 | $31K | |
| 86200 | <1% | 2,132 | $30K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,703 | $30K |
| 84550 | <1% | 6,078 | $28K | |
| 90715 | <1% | 949 | $28K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 2,288 | $27K |
| 93000 | <1% | 1,869 | $26K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 3,681 | $26K |
| 73130 | <1% | 751 | $26K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 394 | $25K |
| 83002 | <1% | 1,269 | $25K | |
| 85007 | <1% | 6,509 | $25K | |
| 90674 | <1% | 1,018 | $24K | |
| 87506 | <1% | 91 | $24K | |
| 86334 | <1% | 983 | $23K | |
| 92550 | <1% | 1,119 | $23K | |
| 83615 | <1% | 3,665 | $23K | |
| 86762 | <1% | 1,581 | $23K | |
| 85652 | <1% | 7,973 | $23K | |
| 87088 | <1% | 2,511 | $22K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,667 | $22K |
| 86803 | <1% | 1,475 | $22K | |
| 87070 | <1% | 2,189 | $21K | |
| 92250 | <1% | 472 | $20K | |
| 82570 | <1% | 4,033 | $20K | |
| 85610 | <1% | 4,513 | $20K | |
| 88342 | <1% | 628 | $20K | |
| 87340 | <1% | 1,729 | $19K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 10,146 | $18K |
| 85730 | <1% | 2,654 | $18K | |
| 86376 | <1% | 1,130 | $17K | |
| 80076 | <1% | 1,909 | $17K | |
| 87631 | <1% | 115 | $17K | |
| 86431 | <1% | 2,714 | $17K | |
| 83690 | <1% | 2,250 | $16K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 267 | $16K |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 178 | $16K |
| 86039 | <1% | 1,282 | $16K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 210 | $15K |
| 76813 | <1% | 133 | $15K | |
| 99443 | <1% | 160 | $15K | |
| 84165 | <1% | 1,283 | $14K | |
| 82150 | <1% | 2,033 | $14K | |
| 99381 | <1% | 134 | $14K | |
| 87653 | <1% | 299 | $13K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 214 | $12K |
| 83020 | <1% | 897 | $12K | |
| 96127 | <1% | 2,435 | $12K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 27 | $12K |
| 83970 | <1% | 284 | $12K | |
| 99442 | <1% | 181 | $12K | |
| 92557 | <1% | 302 | $11K | |
| 73110 | <1% | 279 | $11K | |
| 74018 | <1% | 387 | $10K | |
| 73502 | <1% | 252 | $10K | |
| 83721 | <1% | 941 | $10K | |
| 82785 | <1% | 541 | $10K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 44 | $10K |
| 93015 | <1% | 152 | $10K | |
| 90732 | <1% | 81 | $10K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 55 | $9K |
| 59426 | <1% | 12 | $9K | |
| 82550 | <1% | 1,322 | $9K | |
| 82947 | <1% | 2,161 | $9K | |
| 11900 | <1% | 168 | $9K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 518 | $9K |
| 90661 | <1% | 675 | $9K | |
| 81025 | <1% | 995 | $8K | |
| 87493 | <1% | 209 | $8K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 26 | $8K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 214 | $8K |
| 95819 | <1% | 24 | $8K | |
| 88313 | <1% | 729 | $8K | |
| 84100 | <1% | 1,503 | $7K | |
| 72050 | <1% | 157 | $7K | |
| 99454 | <1% | 168 | $7K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 28 | $7K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,197 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 96,515 | $7K |
| 20553 | <1% | 29 | $7K | |
| 87077 | <1% | 733 | $7K | |
| 85044 | <1% | 1,290 | $6K | |
| 83090 | <1% | 353 | $6K | |
| 90670 | <1% | 4,788 | $6K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 27 | $6K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 57 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 112 | $5K |
| 84460 | <1% | 1,029 | $5K | |
| 93298 | <1% | 241 | $5K | |
| 84450 | <1% | 1,028 | $5K | |
| 90750 | <1% | 25 | $5K | |
| 82627 | <1% | 209 | $5K | |
| 87205 | <1% | 1,158 | $5K | |
| 99386 | <1% | 32 | $5K | |
| 84478 | <1% | 783 | $5K | |
| 85045 | <1% | 1,165 | $5K | |
| 81002 | <1% | 1,353 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 420 | $4K |
| 82248 | <1% | 840 | $4K | |
| 99383 | <1% | 38 | $4K | |
| 86008 | <1% | 14 | $4K | |
| 85018 | <1% | 1,624 | $4K | |
| 93971 | <1% | 39 | $4K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 39 | $4K |
| 84484 | <1% | 327 | $4K | |
| 99441 | <1% | 74 | $4K | |
| 87046 | <1% | 109 | $4K | |
| 76641 | <1% | 27 | $3K | |
| 71271 | <1% | 25 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 237 | $3K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 13 | $3K |
| 71250 | <1% | 24 | $3K | |
| 94010 | <1% | 104 | $3K | |
| 92015 | Determination of refractive state | <1% | 2,250 | $3K |
| 11730 | <1% | 27 | $3K | |
| 85379 | <1% | 253 | $3K | |
| 90632 | <1% | 29 | $3K | |
| 86308 | <1% | 436 | $2K | |
| 93351 | <1% | 12 | $2K | |
| 95115 | <1% | 243 | $2K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 390 | $2K |
| 92582 | <1% | 32 | $2K | |
| 99457 | <1% | 172 | $2K | |
| 95816 | <1% | 14 | $2K | |
| 82951 | <1% | 144 | $2K | |
| 77066 | Tomosynthesis, mammo | <1% | 12 | $2K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 176 | $2K |
| 90746 | <1% | 24 | $2K | |
| 87899 | <1% | 95 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 16 | $2K |
| 96367 | <1% | 38 | $1K | |
| 83525 | <1% | 121 | $1K | |
| 97165 | <1% | 16 | $1K | |
| 95886 | <1% | 12 | $1K | |
| 58300 | <1% | 14 | $1K | |
| 87328 | <1% | 87 | $1K | |
| 87045 | <1% | 109 | $1K | |
| 93224 | <1% | 14 | $1K | |
| 86706 | <1% | 109 | $1K | |
| 86141 | <1% | 77 | $1K | |
| 86735 | <1% | 84 | $1K | |
| 86765 | <1% | 84 | $1K | |
| 11102 | <1% | 12 | $1K | |
| 90620 | <1% | 14 | $1K | |
| 87807 | <1% | 71 | $1K | |
| 87329 | <1% | 72 | $976.66 | |
| 97010 | <1% | 3,399 | $898.47 | |
| 84144 | <1% | 40 | $838.79 | |
| 90688 | <1% | 45 | $813.10 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 505 | $798.63 |
| 90461 | <1% | 8,105 | $767.51 | |
| 72052 | <1% | 12 | $724.33 | |
| 73522 | <1% | 15 | $712.30 | |
| 87427 | <1% | 53 | $708.39 | |
| 86787 | <1% | 56 | $699.04 | |
| 84156 | <1% | 165 | $653.38 | |
| 84436 | <1% | 79 | $597.36 | |
| 96380 | <1% | 27 | $594.54 | |
| 83861 | <1% | 14 | $577.20 | |
| 82952 | <1% | 109 | $491.04 | |
| 72072 | <1% | 12 | $447.24 | |
| 73140 | <1% | 13 | $421.72 | |
| 82977 | <1% | 55 | $408.12 | |
| 87015 | <1% | 56 | $347.40 | |
| 92504 | <1% | 12 | $345.21 | |
| 86709 | <1% | 27 | $334.98 | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 12 | $291.00 |
| 83520 | <1% | 12 | $290.82 | |
| 82378 | <1% | 13 | $263.94 | |
| 99000 | <1% | 46,692 | $262.83 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 243 | $248.72 |
| 90694 | <1% | 13 | $244.29 | |
| 81003 | <1% | 109 | $210.86 | |
| 82247 | <1% | 35 | $191.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,262 | $142.84 |
| 82270 | <1% | 27 | $118.02 | |
| 86580 | <1% | 12 | $92.88 | |
| 82565 | <1% | 14 | $84.17 | |
| 99497 | <1% | 13 | $67.84 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 71 | $32.37 |
| 90647 | <1% | 3,523 | $31.33 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 128 | $16.95 |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | <1% | 65 | $9.38 |
| 90633 | 0% | 1,774 | $0.00 | |
| 90734 | 0% | 923 | $0.00 | |
| 90710 | 0% | 549 | $0.00 | |
| 90700 | 0% | 146 | $0.00 | |
| A4550 | Surgical trays | 0% | 207 | $0.00 |
| 90707 | 0% | 89 | $0.00 | |
| 90685 | 0% | 401 | $0.00 | |
| 90672 | 0% | 150 | $0.00 | |
| 90680 | 0% | 2,972 | $0.00 | |
| 90723 | 0% | 3,579 | $0.00 | |
| 90677 | 0% | 827 | $0.00 | |
| 99024 | 0% | 325 | $0.00 | |
| 90651 | 0% | 338 | $0.00 | |
| 90696 | 0% | 192 | $0.00 | |
| 90716 | 0% | 68 | $0.00 | |
| A9150 | Non-prescription drugs | 0% | 25 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEADLINE, STEPHEN (PRESIDENT)